KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $143.8 million.

  • Opko Health's Net Cash Flow fell 6184.24% to $143.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.1 million, marking a year-over-year decrease of 9600.82%. This contributed to the annual value of $352.9 million for FY2024, which is 71161.74% up from last year.
  • Per Opko Health's latest filing, its Net Cash Flow stood at $143.8 million for Q3 2025, which was down 6184.24% from -$165.7 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Net Cash Flow registered a high of $376.8 million during Q3 2024, and its lowest value of -$165.7 million during Q2 2025.
  • In the last 5 years, Opko Health's Net Cash Flow had a median value of -$13.5 million in 2021 and averaged $18.8 million.
  • Data for Opko Health's Net Cash Flow shows a peak YoY increase of 109096.45% (in 2024) and a maximum YoY decrease of 139172.93% (in 2024) over the last 5 years.
  • Over the past 5 years, Opko Health's Net Cash Flow (Quarter) stood at -$13.5 million in 2021, then crashed by 117.57% to -$29.3 million in 2022, then plummeted by 48.1% to -$43.5 million in 2023, then soared by 171.57% to $31.1 million in 2024, then soared by 362.27% to $143.8 million in 2025.
  • Its Net Cash Flow stands at $143.8 million for Q3 2025, versus -$165.7 million for Q2 2025 and $2.0 million for Q1 2025.